Showing results (91-100 of 809) with videos related to
Sort By:
Pageof 81
Current Opinion in Lipidology|February 12, 2011
Functional validation of new pathways in lipoprotein metabolism identified by human geneticsRobert C Bauer, Ioannis M Stylianou, Daniel J RaderJournal of Clinical Lipidology|February 18, 2014
JCL roundtable: drug treatment of severe forms of familial hypercholesterolemiaW Virgil Brown, Daniel J Rader, Anne C GoldbergCurrent Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J RaderTrends in Molecular Medicine|September 6, 2015
Mining the social mediomeDavid A Asch, Daniel J Rader, Raina M MerchantCurrent Opinion in Lipidology|February 19, 2015
HDL re-examinedG Kees Hovingh, Daniel J Rader, Robert A HegeleFrontiers in Cardiovascular Medicine|March 30, 2022
HDL Composition, Heart Failure, and Its ComorbiditiesAhmed Diab, Carla Valenzuela Ripoll, Zhen Guo, et al.Cardiovascular Diabetology|May 4, 2007
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extentCorinna Lebherz, Julio Sanmiguel, James M Wilson, et al.Prostaglandins & Other Lipid Mediators|November 24, 2005
12/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathwayLei Zhao, Domenico Praticò, Daniel J Rader, et al.Atherosclerosis|September 5, 2002
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient miceMasa-aki Kawashiri, YuZhen Zhang, Ellen Puré, et al.Nutrients|September 28, 2024
Fueling the Heart: What Are the Optimal Dietary Strategies in Heart Failure?Anahita Ataran, Alexander Pompian, Hamidreza Hajirezaei, et al.Pageof 81